Showing posts with label NOSE. Show all posts
Showing posts with label NOSE. Show all posts

Monday, July 31, 2017

HOMOWEOPATHIC REMEDIES FOR NOSE BLEED


Epistaxis or a nosebleed is the relatively common occurrence of hemorrhage  from the nose, usually noticed when the blood  drains out through the nostrils. There are two types: anterior (the most common), and posterior (less common, more likely to require medical attention). Sometimes in more severe cases, the blood can come up the naso lachrymal duct  and out from the eye. Fresh blood and clotted blood can also flow down into the stomach and cause nausea  and vomiting
Although the sight of large amounts of blood can be alarming and may warrant medical attention, nosebleeds are rarely fatal.
HOMOEOPATHIC REMEDIES
FERRUM PHOS  12X and CYNADON DACT. 30—General treatment  for epitaxis. Alternate every 2 hours
MILLIFOLIUM 30 and CROTALUS HOR. 30—When bleeding is very difficult to control
BRYONIA ALB. Q – An excellent remedy , which should be tried first. Bright red blood, on getting up in the morning. Frequent bleeding of nose when menses should appear. Worse by slightest motion . Swelling of tip of nose
CYNADON DACTYLON Q—Epitaxis with bright red blood. Worse from heat of sun after coughing
IPECAC  30—Bright red blood . Constant nausea. Clean tongue
MELILOTUS  30-Epistaxis with intense redness of face
MILLIFOLIUM  Q—A general remedy for all cases of epistaxis when Bryonia  is not effective. Piercing pain from eyes to root of nose
PHOSPHORUS  200—Bleeding  when blowing the nose. Blood is very small and in drops. Handkerchief is always staines with blood. Blood do not coagulate easily. Thirst for icy cold water or drinks. Frequent and profuse hemorrhagic  diathesis
ARNICA MONTANA 200—On coughing or blowing the nose . After every fit of coughing. Dark fluid blood. Nose feels sore and cold
FERRUM PICRICUM  3X—A specific remedy

FICUS RELIGIOSA  Q- An excellent remedy for epistaxis

Friday, July 14, 2017

FROM THE NOSE TO KNEE ENGINEERED CARTILAGE REGENERATES JOINTS




Human articular cartilage defects can be treated with nasal septum cells. Researchers at the University and the University Hospital of Basel report that cells taken from the nasal septum are able to adapt to the environment of the knee joint and can thus repair articular cartilage defects. The nasal cartilage cells' ability to self-renew and adapt to the joint environment is associated with the expression of so-called HOX genes. The scientific journal Science Translational Medicine has published the research results together with the report of the first treated patients.
Cartilage lesions in joints often appear in older people as a result of degenerative processes. However, they also regularly affect younger people after injuries and accidents. Such defects are difficult to repair and often require complicated surgery and long rehabilitation times. A new treatment option has now been presented by a research team lead by Prof. Ivan Martin, professor for tissue engineering, and Prof. Marcel Jakob, Head of Traumatology, from the Department of Biomedicine at the University and the University Hospital of Basel: Nasal cartilage cells can replace cartilage cells in joints.

Cartilage cells from the nasal septum (nasal chondrocytes) have a distinct capacity to generate a new cartilage tissue after their expansion in culture. In an ongoing clinical study, the researchers have so far taken small biopsies (6 millimeters in diameter) from the nasal septum from seven out of 25 patients below the age of 55 years and then isolated the cartilage cells. They cultured and multiplied the cells and then applied them to a scaffold in order to engineer a cartilage graft the size of 30 x 40 millimeters. A few weeks later they removed the damaged cartilage tissue of the patients' knees and replaced it with the engineered and tailored tissue from the nose. In a previous clinical study conducted in cooperation with plastic surgeons and using the same method, the researchers from Basel recently already successfully reconstructed nasal wings affected by tumors.

Surprising Adaption
The scientists around first author Dr. Karoliina Pelttari were especially surprised by the fact that in the animal model with goats, the implanted nasal cartilage cells were compatible with the knee joint profile; even though, the two cell types have different origins. During the embryonic development, nasal septum cells develop from the neuroectodermal germ layer, which also forms the nervous system; their self-renewal capacity is attributed to their lack of expression of some homeobox (HOX) genes. In contrast, these HOX genes are expressed in articular cartilage cells that are formed in the mesodermal germ layer of the embryo.

"The findings from the basic research and the preclinical studies on the properties of nasal cartilage cells and the resulting engineered transplants have opened up the possibility to investigate an innovative clinical treatment of cartilage damage," says Prof. Ivan Martin about the results. It has already previously been shown that the human nasal cells' capacity to grow and form new cartilage is conserved with age. Meaning, that also older people could benefit from this new method, as well as patients with large cartilage defects. While the primary target of the ongoing clinical study at the University Hospital of Basel is to confirm the safety and feasibility of cartilage grafts engineered from nasal cells when transplanted into joint, the clinical effectiveness assessed until now is highly promising.